Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Jean-Paul Clozel
Age : 63
Public asset : 807,218,103 USD
Country of residence : Unknown
Linked companies : Idorsia Ltd

Summary 
Dr. Jean-Paul Clozel, MD, is Chief Executive Officer at Actelion Pharmaceuticals UK Ltd.

He is on the Board of Directors at Idorsia Ltd. Dr. Clozel was previously employed as Chief Executive Officer & Executive Director by Actelion Ltd. and Head-Drug Discovery Group by F. Hoffmann-La Roche Ltd.


Current positions of Jean-Paul Clozel 
NameTitle Since
Idorsia Ltd
(Biotechnology & Medical Research)
Chief Executive Officer & Director 2017
Actelion Pharmaceuticals UK Ltd. Chief Executive Officer 1997


Holdings of Jean-Paul Clozel 
NameEquities%Valuation
Idorsia Ltd (IDIA)
Biotechnology & Medical Research
30,908,99625.9%807,218,103 USD


Jean-Paul Clozel : Personal Network 




Most Read News 
02/16 WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
02/13 STEPHEN SCHWARZMAN : Blackstone appoints real estate boss Gray as Schwarzman's successor
02/15 PETER THIEL : Tech Luminary Peter Thiel Parts Ways With Silicon Valley
02/14 ROBIN LI : Baidu earnings beat forecasts, eyes U.S. listing for video unit iQiyi
02/12 JEAN-PIERRE CLAMADIEU : French government backs Solvay's Clamadieu as new Engie chairman
02/15 DAVID THOMSON : Thomson Reuters Chairman Criticized Its $17 Billion Deal with Blackstone
02/16 VINCENT BOLLORÉ : Vivendi shares drop as French group's lack of guidance underwhelms
02/13 STEVE WYNN : Top Company News of the Day
02/16 ROMAN ABRAMOVICH : Co-owners of Russia's Nornickel back in fight for control
02/12 CARLOS GHOSN : France backs Renault COO nomination, seeks Nissan integration
More news


© 2018 People and Ownership :   
Advertisement
Jean-Paul Clozel : Connections 
Alzheon, Inc.
Advanced Respiratory, Inc.
Max Planck Institute For Biophysical Chemistry
NanoBio Corp.
Actelion Pharmaceuticals Ltd.
The Confederation of Netherlands Industry Employers
Shire Pharmaceuticals, Inc.
Actelion Pharmaceuticals UK Ltd.
Newman's Own Foundation
Advanced Medical Technology Association


Latest news about Jean-Paul Clozel 
02/11IDORSIA LTD : Europe’s most promising biotech firm?
2017IDORSIA : Actelion, bis repetita ?
2017 ACTELION : J&J Maps Research Plans for Actelion -- WSJ
2017 ACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
2017 ACTELION : Johnson & Johnson expects to complete Actelion purchase on June 16
2017 ACTELION : Johnson & Johnson expects to complete Actelion purchase on June 16
More news


Popular Business Leaders 
Bernard Arnault Jeff Bezos Kurt Bock Vincent Bolloré Warren Buffett Jean-pierre Clamadieu Tim Cook Richard Cousins Elmar Degenhart Michael Dell Jamie Dimon Patrick Drahi Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Ingvar Kamprad Dara Khosrowshahi Isabelle Kocher Bruno Lafont Jack Ma Sergio Marchionne Gérard Mestrallet Laurent Mignon Lakshmi Mittal Rupert Murdoch Elon Musk Peter Nicholas Michael O'leary Nelson Peltz Sumner Redstone Alexandre Ricard Stéphane Richard Xavier Rolet Kasper Rorsted Eric Schmidt Charles Schwab George Soros Rupert Stadler Bernard Tapie Peter Terium Peter Thiel François Villeroy De Galhau Meg Whitman John Williamson Thomas Wilson Elaine Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders